Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Portfolio Pulse from Avi Kapoor
Wall Street analysts have updated their price targets and ratings for several companies. Citigroup raised Deckers Outdoor's target but downgraded the stock to Neutral. HC Wainwright cut Applied DNA Sciences' target but maintained a Buy rating. Jefferies downgraded Beam Therapeutics and lowered its target. Citigroup increased Dollar General's target while maintaining a Neutral rating. Morgan Stanley upgraded First Solar and raised its target. Barclays raised Lululemon's target and kept an Overweight rating. Keybanc lowered Veeva Systems' target but kept an Overweight rating. Raymond James increased Toll Brothers' target and maintained a Strong Buy rating. Deutsche Bank raised Cintas' target but downgraded the stock to Hold. Telsey Advisory cut RH's target and maintained a Market Perform rating.
December 08, 2023 | 12:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup increased Dollar General's price target from $115 to $138 and maintained a Neutral rating.
The raised price target is a positive sign, but the Neutral rating indicates that the stock might not have a strong short-term movement.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Morgan Stanley upgraded First Solar to Overweight from Equal-Weight and raised the price target from $214 to $237.
The upgrade to Overweight and increased price target indicate a strong positive sentiment that could lead to a short-term rally.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Barclays raised Lululemon's price target from $480 to $530 and maintained an Overweight rating.
The increased price target and continued Overweight rating suggest confidence in the stock's potential, likely leading to a positive short-term impact.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Raymond James increased Toll Brothers' price target from $110 to $120 and maintained a Strong Buy rating.
The raised price target and Strong Buy rating indicate a very positive outlook, which could lead to a short-term increase in the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 85
NEUTRAL IMPACT
Deutsche Bank raised Cintas' price target from $551 to $590 but downgraded the stock from Buy to Hold.
The price target increase is positive, but the downgrade to Hold suggests that the stock may not see significant short-term movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Citigroup raised Deckers Outdoor's price target from $665 to $710 but downgraded the stock from Buy to Neutral.
The price target increase is positive, but the downgrade to Neutral suggests limited upside potential, likely resulting in a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Keybanc lowered Veeva Systems' price target from $230 to $210 but maintained an Overweight rating.
The price target cut could be seen as a negative, but the Overweight rating may balance it out, leading to a neutral short-term impact.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
HC Wainwright cut Applied DNA Sciences' price target from $4 to $2 but maintained a Buy rating.
The significant price target reduction could negatively impact investor sentiment despite the maintained Buy rating.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Jefferies downgraded Beam Therapeutics from Buy to Hold and cut the price target from $75 to $30.
The downgrade and significant price target cut suggest a bearish view that could lead to a negative short-term impact on the stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Telsey Advisory cut RH's price target from $325 to $285 and maintained a Market Perform rating.
The reduced price target could negatively affect the stock, but the Market Perform rating indicates a lack of strong sentiment either way.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70